SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:235757444"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:235757444" > aMMP-8 Oral Fluid P...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002963naa a2200409 4500
001oai:prod.swepub.kib.ki.se:235757444
003SwePub
008240701s2022 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:2357574442 URI
024a https://doi.org/10.3389/froh.2022.8971152 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Sorsa, Tu Karolinska Institutet4 aut
2451 0a aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases
264 c 2022-06-10
264 1b Frontiers Media SA,c 2022
520 a The manuscript uses the previously published literature and highlights the benefits of active-matrix metalloproteinase (aMMP)-8 chairside/point-of-care (PoC) diagnostic tools as adjunctive measures in oral and systemic diseases. Previous studies suggest that as a biomarker, aMMP-8 is more precise than total MMP-8, MMP-9, MMP-2, MMP-3, MMP-13, MMP-7, MMP-1, calprotectin, myeloperoxidase (MPO), human neutrophil elastase (HNE), tissue inhibitor of matrix metalloproteinase (TIMP)-1, and bleeding of probing (BOP). Therefore, aMMP-8 could be implemented as the needed key biomarker for the new disease classification for both periodontitis and peri-implantitis. With a sensitivity to the tune of 75–85% and specificity in the range of 80–90%, lateral flow aMMP-8 PoC testing is comparable to catalytic protease activity assays for aMMP-8. The test can be further applied to estimate the glycemic status of an individual, to ascertain whether a person is at risk for COVID-19, in managing the oral side effects of radiotherapy carried in head and neck cancers, and in selected cases pertaining to reproductive health. In the future, aMMP-8 could find application as a potential systemic biomarker in diseases affecting the cardiovascular system, cancers, bacteremia, sepsis, diabetes, obesity, meningitis, as well as pancreatitis. The aMMP-8 PoCT is the first practical test in the emerging new dental clinical field, that is, oral clinical chemistry representing oral medicine, clinical chemistry, peri-implantology, and periodontology.
700a Nwhator, SO4 aut
700a Sakellari, D4 aut
700a Grigoriadis, A4 aut
700a Umeizudike, KA4 aut
700a Brandt, E4 aut
700a Keskin, M4 aut
700a Tervahartiala, T4 aut
700a Pärnänen, P4 aut
700a Gupta, S4 aut
700a Mohindra, R4 aut
700a Bostanci, Nu Karolinska Institutet4 aut
700a Buduneli, N4 aut
700a Räisänen, IT4 aut
710a Karolinska Institutet4 org
773t Frontiers in oral healthd : Frontiers Media SAg 3, s. 897115-q 3<897115-x 2673-4842
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:235757444
8564 8u https://doi.org/10.3389/froh.2022.897115

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view